잠시만 기다려 주세요. 로딩중입니다.
제목 2017 대한폐암학회 추계학술대회 안내
기간 2017.11.23 - 2017.11.24
글쓴이 관리자
첨부파일
학술행사 안내
일시: 2017년 11월 23일 (목) ~ 24일 (금)
장소: Lotte Jamsil Hotel Sapphire room
연수평점: 12점 (부분평점 인정)
홈페이지 : http://www.lungca.or.kr/abstract/2017_fall/
사전등록
사전등록 마감일: 2017년 11월 13일(월)까지 연장
자세한 내용은 사전등록 안내 메뉴를 참고 하시기 바랍니다.
프로그램
Nov, 23rd (Thu)
Crystal 1Crystal 2Crystal 3
08:30-08:50Registration
08:50-09:00Opening Remark
 Session I-1.NGS
좌장 : 이건국 (국립암센터)
Session I-2. Lung cancer genomics좌장 : 장세진 (울산의대)
09:00-09:20NGS기반 유전자 패널검사의 질관리손대순 (삼성유전체 연구소)09:00-09:30 NGS data -based Artificial Intelligence Model for Cancer-Drug-Response Profiling 정종선 (신테카 바이오)
09:20-09:40 NGS 기반 유전자 패널 검사 급여화 배경 및 전망심효섭 (연세의대)09:30-10:00 Study for cancer genomics; whats left?김주한 (서울대)
09:40-10:00 NGS 기반 유전자 패널 검사의 기관별 상황 및 전망 I김지훈 (울산의대)10:00-10:30 Genomic data sharing; implications & hurdles정연준(가톨릭의대)
10:00-10:20 NGS 기반 유전자 패널 검사의 기관별 상황 및 전망 II김태정 (가톨릭의대) 
10:20-10:30Q&A 
10:30-11:00Coffee Break
 Plenary Session 좌장 : 조문준 (충남의대)
11:00-11:50The Healthcare Innovation for the precision cancer medicine with IBM Watson Health? Annette Hicks (Watson Health, IBM)
11:50-12:00Q&A
 Luncheon Symposium I좌장 : 김상위 (울산의대)
12:00-12:40Big Stride in 1L NSCLC treatment: moving from chemotherapy to anti- PD 1 therapy (MSD)Raffaele Califano
(The Christie NHS Foundation Trust and University Hospital of South Manchester)
12:40-13:00Coffee Break
 Oral Presentation
13:00~13:10Chemopreventive effect of long-term use of low-dose aspirin on lung cancer risk A nationwide study considering competing risk
천은미 (이화의대)
13:00~13:10Weekly Docetaxel as first-line chemotherapy in elderly patients with advanced squamous cell non-small cell lung cancer : phase II study
최종현 (고려의대)
13:00~13:10폐암 환자를 대상으로 개인 맞춤형 호흡 재활 서비스(숨튼 PHR®)의 임상적 효과를 확인하기 위한 전향적 연구
지원준 (울산의대)
13:10~13:20Bone Metastasis is associated with Osteoporosis Risk Among Lung Cancer Patients
이승룡 (고려의대)
13:10~13:20Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
박송이 (성균관의대)
13:10~13:20Generative Model of Functional RT-Plan Chest CT for Lung Cancer Patients Using Machine Learning Algorithm
장범섭 (서울의대)
13:20~13:30Role of low-dose computerized tomography in lung cancer screening among never-smokers
강혜린 (서울의대)
13:20~13:30Clinical characteristics of lung cancer with programmed death-ligand 1 expression
박하영 (전남의대)
13:20~13:30Generation of predicted tumor-regression computed tomography image during definitive concurrent chemo-radiotherapy of the lung cancer using deep learning technique
김경수 (동남권원자력의학원)
13:30~13:40Comparison of PD-L1 Expression on Cell Block and Matched Resection Specimens from Lung Cancer
노미숙 (동아의대)
13:30~13:40Continuing Gefitinib beyond progression in patients with EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A phase II single-arm prospective trial
임성원 (성균관의대)
13:30~13:40Initial PET/CT maximal SUV as a Biologic Predictive Factor Prognostic of Outcome in Early-stage NSCLC after SABR
곽유강 (가톨릭의대)
13:40~13:50Extracellular vesicle DNA for liquid biopsy
허재영 (건국의대)
13:40~13:50Outcomes of T790M+ lung cancer patients treated with osimertinib in real world practice after acquired resistance to the previous EGFR-TKI in Korea
오동규 (울산의대)
13:40~13:50Exosomes Increase More at Pulmonary Vein than Peripheral Vessel in Lung Cancer: based on preclinical and clinical studies
김현구 (고려의대)
13:50~14:00Detection and dynamic change of EGFR mutation status in plasma and comparison of tissue from NSCLC patients
이윤경 (울산의대)
13:50~14:00Phase II Trial of AZD9291 in Second-Line Treatment after Acquired Resistance with T790M Mutation Detected From Circulating Tumor DNA (LiquidLung-O-Cohort 2)
김영철 (전남의대)
13:50~14:00Prognostic Factor and Survival of Patients with Resected stage IIIA N2 Lung Adenocarcinoma
김제훈 (울산의대)
14:00~14:10Feasibility and alternative approaches of rebiopsy in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors
김희정 (건국의대)
14:00~14:10Tumor-derived microvesicles promote the immune surveillance of tumor through PD-1/PD-L1 interaction
김동하 (울산의대)
14:00~14:10Feasibility of lobectomy and mediastinal node dissection by video-assisted thoracoscopic surgery following neoadjuvant?chemoradiaotherapy for stage IIIA N2?lung cancer: Propensity matching analysis
전영정 (성균관의대)
14:10~14:20Feasibility of Liquid Biopsy Using Plasma and Platelets for Detection of ALK Rearrangements in Non-Small Cell Lung Cancer
박철규 (전남의대)
14:10~14:20Glucose Supports EGFR-mutant Lung Adenocarcinoma Cell Survival by Inhibiting Autophagy-mediated EGFR Degradation
노진경 (울산의대)
14:10~14:20Diffusing capacity(DLco) decrement following neoadjuvant concurrent chemoradiotherapy :implication on postoperative pulmonary complications in lung cancer patients
신수민 (성균관의대)
14:20-14:40Coffee Break
 Session II-1. In-depth review of 8th TNM staging
좌장 : 이춘택 (서울의대)
Session II-2. Screen-detected Ground Glass Nodules좌장 : 나국주 (전남의대)Session II-3. Emerging field of Radiomics
좌장 : 용환석 (고려의대)
14:40-15:05 TNM staging; pulmonologists
perspective황보빈 (국립암센터)
14:40-15:00 Management strategy and guideline: follow-up vs. surgery전재현 (국립암센터)Basics of image processing in radiomics 김남국 (울산의대)
15:05-15:30 TNM staging;
radiologists perpective안명임 (가톨릭의대)
15:00-15:20 Preoperative workup: Bronchoscopy/EBUS, brain MRI, PET/ CT, Biopsy are needed?조정수 (부산의대)Radiomics: the current status이호연 (성균관의대)
15:30-15:55 TNM staging; surgeons perspective이진구 (연세의대)15:20-15:40 Localization technique조석기 (서울의대)Radiomics and beyond: limitations and future directions박창민 (서울의대)
15:55-16:10Q&A15:40-16:00 Surgical procedure: Optimal extent of pulmonary resection
and mediastinal LN assessment
김홍관 (성균관의대)
Q&A
16:00-16:10Q&A 
16:10-16:40Coffee Break
 Session III-1. Neuroendocrine
tumors other than SCLC좌장 : 김관민 (서울의대)
Session III-2. Thymic Epithelial Tumors
좌장 : 오영택 (아주의대)
Session III-3. SCLC

좌장 : 안명주 (성균관의대)
16:40-17:00 Pathology of neuroendocrine tumor하승연 (가천의대)Review of staging and pathologic classification노미숙 (동아의대)Novel chemotherapeutic agent in SCLC김혜련 (연세의대)
17:00-17:20 Surgery김형렬 (울산의대)Recent updates of chemotherapy안희경 (가천의대)Role of radiation therapy in extensive disease SCLC김학재 (서울의대)
17:20-17:40Chemotherapy for large cell neuroendocrine carcinoma선종무 (성균관의대)Radiotherapy for Thymic Tumors송상혁 (강원의대)Role of surgery in SCLC이호석 (부산의대)
17:40-18:00Coffee Break
 Dinner Symposium (Sapphire room)좌장 : 김영철 (전남의대)
18:00-18:50Recent update with clinical practice of Atezolizumab in NSCLC (Roche)한지연 (국립암센터)


Nov, 24th (Fri)
Crystal 1Crystal 2Crystal 3
08:30-08:50Registration
08:50-09:00Opening Remark
 Korea-Japan Joint Symposium (Peri-operative treatment of lung cancer)좌장 : Young Tae Kim (Seoul National University ), Masahiro Tsuboi (National Cancer Center East)
 Part I
09:00-09:30Current guideline of peri-operative treatment
Hirotsugu Kenmotsu (Devision of Thoracic Oncology, Shizuoka Cancer Center)
09:30-10:00 A long debating issue; neoadjuvant vs adjuvant therapy in N2+ stage III lung cancerJhingook Kim (Sungkyunkwan University)
10:00-10:20Coffee Break
 Part I
10:20-10:50 Role of radiotherapy on peri-operative treatmentYuko Nakayama (Department of Radiation Oncology, National Cancer Center Hospital)
10:50-11:20 Application of new medical treatments such as target therapy and immunotherapy in adjuvant settingJeong Eun Lee (Chungnam National University)
11:20-11:30Wrap-up and introduction of next joint symposium in Japan
11:30-12:00General Assembly
 Luncheon Symposium II좌장 : 인광호 (고려의대)
12:00-12:40Optimal Strategy & Recent updates in Treatment of T790M+ NSCLC (AZ)이승룡 (고려의대)
12:40-13:10Coffee Break
 Session IV. Updates on Immuno-Oncology좌장 : 강진형(가톨릭의대)
13:10-13:40Immune-related adverse effects of immunotherapyTe-Chun Hsia (China Medical University and Hospital)
13:40-14:10PD-L1 and other biomarkers in immunotherapyHo, James Chung Man (Hong Kong University)
14:10-14:40Combination strategy of immunotherapy in NSCLCRoss soo (National University Cancer Institue)
14:40-15:10Coffee Break
 Session V. Interactive session
15:10-15:50Management of multi-station or/and bulky N2-IIIA NSCLC선종무 (성균관의대)
 패널 : 이대호 (울산의대), 김홍관 (성균관의대), 안성자 (전남의대)
15:50-16:30Approach to multifocal lung cancer장승훈 (한림의대)
 패널 : 김연실 (가톨릭의대), 이신엽(경북의대), 김현구 (고려의대)
16:30-16:50Award Ceremony
16:50-17:00Closing Remark

2017-11-13 오후 4:16:34, 조회수 : 316